Brightsurf Science News & Current Events

August 28, 2016
iPads as effective as sedatives for children before operations
New research presented at this year's World Congress of Anaesthesiologists in Hong Kong (Aug.

Sudden death in hypertrophic cardiomyopathy rarely associated with exercise
Sudden death in patients with hypertrophic cardiomyopathy (HCM) is rarely associated with exercise, according to research presented at ESC Congress 2016 today by Dr.

The REM-HF trial: Remote monitoring of implantable cardiac devices: No added benefit
For heart failure patients with cardiac implantable electronic devices (CIEDs), remote monitoring of their condition does not improve outcomes compared to usual care, according to Hot Line results presented at ESC Congress 2016 and to be simultaneously published in JAMA.

Heart failure in the elderly set to triple by 2060
Heart failure in the elderly is set to triple by 2060, according to new data from the Age, Gene/Environment Susceptibility (AGES) -- Reykjavík study presented at ESC Congress 2016 today.

An unbalance in nutrients threatens plant biodiversity
An unnatural balance of nutrients threatens biodiversity in a survival of the fittest scenario, according to the results of a world-first global experiment published in the prestigious Nature journal.

Asthma care costs UK at least £1.1 billion each year, study shows
Asthma costs the UK health service at least £1.1 billion each year, research led by the University has estimated.

SAVE: Sleep apnea treatment: No cardiovascular benefit
More than three years of nightly treatment with a continuous positive airway pressure machine did not reduce cardiovascular risk more than usual care among patients with cardiovascular disease and obstructive sleep apnea.

Mediterranean diet associated with lower risk of death in cardiovascular disease patients
The Mediterranean diet is associated with a reduced risk of death in patients with a history of cardiovascular disease, according to results from the observational Moli-sani study presented at ESC Congress 2016 today.

Up to 80 percent of heart failure patients denied therapy to reduce hospitalization and death
A study in nearly 15,000 heart failure patients has found that up to 80 percent may not be receiving treatment at doses proven to reduce hospitalizations and improve survival.

CHART-1: Largest cardiac regenerative therapy trial brings new insights
A therapy that uses bone-marrow stem cells to promote heart repair did not significantly improve the primary outcome over a sham procedure among patients with congestive heart failure.

Parkinson's study could pave way for early detection test
A test that can detect Parkinson's disease in the early stages of the illness has moved a step closer.

Traffic accidents increased by 50 percent in patients with implantable cardioverter defibrillator
The risk of traffic accidents is increased by 50 percent in patients with an implantable cardioverter defibrillator compared to age and gender matched controls, according to a Danish nationwide registry study presented at ESC Congress 2016 today.

Infused stem cells in heart failure: Improved health status but not cardiac function
A single dose of mesenchymal stem cells delivered intravenously to patients with chronic non-ischemic cardiomyopathy was not associated with significant cardiac structural or functional improvements, but did result in several clinically relevant benefits, according to results from a phase II-a randomized trial.

DANISH: No overall survival benefit with ICDs in non-ischemic heart failure
Placement of an implantable cardioverter-defibrillator (ICD) in patients with non-ischemic systolic heart failure did not improve overall survival compared to usual clinical care -- although a secondary outcome, risk of sudden cardiac death, was halved with ICD placement, according to new research reported here.

Increased risk of death for heart failure patients with each NHS hospital admission
Heart failure patients have a 2 percent increased risk of dying with each admission to NHS hospitals, according to research presented at ESC Congress 2016 today.

ANTARCTIC trial antiplatelet monitoring: No benefit in elderly patients
Monitoring platelet function in order to individualize antiplatelet therapy did not improve outcomes for elderly patients after a heart attack compared to a standard, unmonitored approach, results of the ANTARCTIC trial show.

Shorter dual antiplatelet duration holds up in NIPPON
A short-term course of dual antiplatelet therapy is non-inferior to a longer course in patients who have undergone placement of a particular kind of drug-eluting stent, researchers reported here.

MORE-CARE: No clinical benefit for cardiac device remote monitoring
Heart failure patients fitted with biventricular defibrillators fared no better with remote monitoring of their condition compared to those whose devices were monitored during in-clinic visits, according to results of the MORE-CARE study.

Defibrillators could save many more lives if associated with basic life support education
Automatic external defibrillators fail to save lives when the public does not have basic life support education, according to research presented today at ESC Congress 2016.

Nebivolol prevents anthracycline-induced cardiotoxicity
Nebivolol prevents anthracycline-induced cardiotoxicity, according to research presented at ESC Congress 2016 today by Professor Mirela Cleopatra Tomescu, a cardiologist at Victor Babes University of Medicine and Pharmacy, Timisoara, Romania. is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to